RXST

4.4703.04%
MW

Mark Wilterding

Chief Financial Officer

Mr. Mark Wilterding is Chief Financial Officer of RxSight, Inc. from January 11, 2026. He oversaw investor relations, financial planning and analysis, treasury, financial operations and strategy and regional finance teams. Mr. Wilterding has financial leadership experience, serving as the Senior Vice President of Global Finance for Edwards Lifesciences, where he joined in 2019. Mr. Wilterding was Vice President of Investor Relations at Edwards Lifesciences Corporation. He was Director of Investor Relations at Medtronic plc. Prior to joining Edwards Lifesciences, Mr. Wilterding worked for Medtronic and spent years of his career at Citi and Credit Suisse. He received a B.A. in economics and English from St. Olaf College and an M.B.A. in finance, management and strategy and marketing from the Kellogg School of Management at Northwestern University.

Positions